Outcomes of offspring born to mothers with gestational diabetes

Area of Science:

• Reproductive Medicine
• Endocrinology
• Pediatric Health

Background:

• Diabetes and obesity are global epidemics, with Asia as a major epicenter.
• Approximately 1 in 7 live births are affected by hyperglycemia, including pre-existing and gestational diabetes.
• Adverse in utero metabolic environments pose risks for offspring development.

Purpose of the Study:

• To examine the consequences of maternal hyperglycemia on offspring.
• To understand the link between fetal metabolic programming and long-term health outcomes.
• To evaluate the impact of novel management strategies on perinatal outcomes.

Main Methods:

• Review of existing literature on maternal hyperglycemia and offspring outcomes.
• Analysis of the correlation between maternal glycemic control and adverse perinatal events.
• Assessment of the effectiveness of management strategies targeting normoglycemia.

Main Results:

• Maternal hyperglycemia is associated with multisystemic congenital malformations, macrosomia, and perinatal metabolic derangements.
• In utero exposure to adverse metabolic conditions can lead to epigenetic changes, 'metabolic memory,' and increased risk of childhood obesity, metabolic syndrome, and diabetes.
• Poor glycemic control during pregnancy correlates with adverse outcomes for the offspring.

Conclusions:

• Near-normoglycemia management in pregnancy significantly improves perinatal mortality and reduces adverse outcomes.
• Careful selection of diabetes therapies during pregnancy is crucial, prioritizing offspring safety.
• Addressing maternal hyperglycemia is vital for preventing long-term metabolic health issues in children.